Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)
2016-01-01 Leone, ; Marino, ; Cereda, ; Filippi, ; Belli, ; Spadi, ; Nasti, ; Montano, ; Amatu, ; Aprile, ; Cagnazzo, ; Fasola, ; Siena, ; Ciuffreda, ; Reni, M; Aglietta,
Quality-Adjusted survival with combination nab-paclitaxel+gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: A Q-TWiST analysis
2014-01-01 Reni, M; Wan, Y; Solem, C; Whiting, S; Ji, X; Botteman, M
High-dose chemotherapy supported by autologous stem cell transplantation in patients with primary central nervous system lymphoma: facts and opinions
2008-01-01 Ferreri, Ajm; Crocchiolo, R; Assanelli, A; Govi, S; Reni, M
Quality of life assessment in advanced pancreatic adenocarcinoma: Results from a phase III Randomized trial
2006-01-01 Reni, M; Bonetto, E; Cordio, S; Passoni, P; Milandri, C; Cereda, S; Spreafico, A; Galli, L; Bordonaro, R; Staudacher, C; Di Carlo, V; Johnson, Cd
Primary brain lymphomas in patients with a prior or concomitant malignancy
1997-01-01 Reni, M; Ferreri, Ajm; Zoldan, Mc; Villa, E
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
2016-01-01 Chiorean, ; E., G.; Von, Hoff; D., D.; Reni, M; Arena, ; F., P.; Infante, ; J., R.; Bathini, ; V., G.; Wood, ; T., E.; Mainwaring, ; P., N.; Muldoon, ; R., T.; Clingan, ; P., R.; Kunzmann, ; Ramanathan, ; R., K.; Tabernero, ; Goldstein, ; Mcgovern, ; Lu, ; Ko,
Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors
2017-01-01 Aspeslagh, S; Shailubhai, K; Bahleda, R; Gazzah, A; Varga, A; Hollebecque, A; Massard, C; Spreafico, A; Reni, M; Soria, J-C
A retrospective analysis of postradiation chemotherapy in 133 patients with glioblastoma multiforme
2000-01-01 Reni, M; Cozzarini, C; Ferreri, Ajm; Ceresoli, Gl; Galli, L; Bianchi, A; Villa, E
Primary central nervous system lymphoma - Biological aspects and controversies in management
2007-01-01 Bessell, Em; Hoang-Xuan, K; Ferreri, Ajm; Reni, M
Evidences and Opinions for Adjuvant Therapy in Pancreatic Cancer
2012-01-01 Reni, M
On the isometry groups of cyclic branched coverings of hyperbolic knots
2000-01-01 Reni, M
Adjuvant treatment in biliary tract cancer: To treat or not to treat?
2012-01-01 Cereda, S; Belli, C; Reni, M
Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
2006-01-01 Mirimanoff, Ro; Gorlia, T; Mason, W; Van den Bent, Mj; Kortman, Rd; Fisher, B; Reni, M; Brandes, Aa; Curschmann, J; Villa, S; Cairncross, G; Allgeier, A; Lacombe, D; Stupp, R
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial
2013-01-01 Reni, M; Cereda, ; Milella, ; Novarino, ; Passardi, ; Mambrini, ; Di, Lucca; Aprile, ; Belli, ; Danova, ; Bergamo, ; Franceschi, ; Fugazza, ; Ceraulo, ; Villa,
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial
2010-01-01 Joerger, M; Huitema, Adr; Krahenbuhl, S; Schellens, Jhm; Cerny, T; Reni, M; Zucca, E; Cavalli, F; Ferreri, Ajm
Primary central nervous system lymphomas: Salvage treatment after failure to high-dose methotrexate
2007-01-01 Reni, M; Mazza, E; Foppoli, M; Ferreri, Ajm
Metastatic pancreatic cancer: Is there a light at the end of the tunnel?
2015-01-01 Vaccaro, ; Sperduti, ; Vari, ; Bria, ; Melisi, ; Garuf, ; Nuzzo, ; Scarpa, ; Tortora, ; Cognetti, ; Reni, M; Milella,
Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy
2011-01-01 Giovannetti, E; Pacetti, P; Reni, M; Leon, Lg; Mambrini, A; Vasile, E; Ghidini, M; Funel, N; Lucchesi, M; Cereda, S; Peters, Gj; Cantore, M
Neoadjuvant treatment for resectable pancreatic cancer: Time for phase III testing?
2010-01-01 Reni, M
Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL)
2017-01-01 Annemans, ; Aymé, ; Le, Cam; Facey, ; Gunther, ; Nicod, ; Reni, M; Roux, ; J., -L.; Schlander, ; Taylor, ; Tomino, ; Torrent-Farnell, ; Upadhyaya, ; Hutchings, ; Le, Dez
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40134
Data di pubblicazione
- In corso di stampa9
- 2020 - 202712186
- 2010 - 201915980
- 2000 - 20097460
- 1990 - 19993486
- 1980 - 1989935
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.823
- Elsevier B.V.809
- Springer Science and Business Med...552
- John Wiley and Sons Inc549
- Oxford University Press506
- Lippincott Williams and Wilkins435
- Springer374
- Elsevier Ltd350
- MDPI348
- Springer Nature296
Rivista
- EUROPEAN UROLOGY535
- BLOOD372
- PLOS ONE313
- JOURNAL OF NEUROLOGY291
- EUROPEAN JOURNAL OF HEART FAILURE281
- NEUROLOGY270
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL225
- MULTIPLE SCLEROSIS219
- SCIENTIFIC REPORTS215
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19636
- Retrospective Studies628
- Treatment Outcome603
- Prognosis483
Lingua
- eng29490
- ita1971
- fre65
- und55
- spa34
- ger26
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext32003
- reserved4297
- open3722
- partially open104
- embargoed7
- mixed1